P4‐102: TWO PILOT STUDIES OF THE ALPHA‐1 ADRENORECEPTOR ANTAGONIST PRAZOSIN FOR AGITATION/AGGRESSION IN AD LEAD TO AN ALZHEIMER'S DISEASE COOPERATIVE STUDY MULTICENTER TRIAL. (1st July 2014)